About Cooper Pharma Limited
Data last updated: 23 December 2025
Cooper Pharma Limited is a public limited company based in Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 February 1989, the company has been in operation for over 37 years.
Registered with ROC Delhi under CIN U24231DL1989PLC034902.
Capital: an authorised share capital of ₹3 Cr and a paid-up capital of ₹1 Cr. Formerly known as Cooper Pharma Private Limited. It is led by directors including Rakesh Bhargava and Dinesh Kumar.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. – 5 Nidhi Plaza – Ii 2Nd Floor, L.S.C. Gulabi Bagh, Delhi, Delhi, India – 110052.
As per the financials filed for FY 2024, the company reported a revenue of ₹63.28 Cr, a decline of 1% compared to the previous year.
The company has a workforce of approximately 122 employees as per the latest available data.
The company is associated with 1 brand - Cooper Pharma. As per MCA filings, the company has open charges of ₹3.03 Cr and satisfied charges of ₹22.6 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cooperpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No. – 5 Nidhi Plaza – Ii 2Nd Floor, L.S.C. Gulabi Bagh, Delhi, Delhi, India – 110052
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Cooper Pharma Limited
Cooper Pharma Limited operates one associated brand: Cooper Pharma. These brands represent Cooper Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures generic pharmaceuticals and exports to over 25 countries. | cooperpharma.com |
Competitors & Alternatives of Cooper Pharma Limited
Brands and companies operating in the same space as Cooper Pharma Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
MedPharm
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Cooper Pharma Limited
Cooper Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Cooper Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Cooper Pharma Limited
Cooper Pharma Limited is audited by P.C BINDAL & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P.C BINDAL & CO. | Locked | Locked | Locked |
Complete auditor history for Cooper Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cooper Pharma Limited
Cooper Pharma Limited is currently managed by 3 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rakesh Bhargava
Also directs:
Cooper Life Sciences Private Limited, Cooper Biotech Private Limited, Dw Customer Support Private Limited and 1 more
|
Managing Director | 02 Feb 1989 | 37 Years 5 Months | Current |
| Dinesh Kumar | Director | 05 Jun 2024 | 2 Years 1 Months | Current |
| Abhishek Bhargava | Whole-Time Director | 01 Aug 2009 | 16 Years 11 Months | Current |
Financials of Cooper Pharma Limited FY 2025 filings available
Cooper Pharma Limited reported revenue of ₹63.28 Cr (down 1.00% YoY) for FY 2024.
Ten-year financial statements for Cooper Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cooper Pharma Limited
Shareholding and ownership data for Cooper Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Cooper Pharma Limited
Cooper Pharma Limited has 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Cooper Pharma Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Cooper Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2011 | Punjab National Bank | ₹2.5 Lakh | Open |
| 28 Mar 2006 | Small Industries Developmnt Bank of India | ₹3 Cr | Open |
| 02 Apr 2025 | Others | ₹12.5 Cr | Satisfied |
| 04 Jul 2018 | Others | ₹9.9 Lakh | Satisfied |
| 13 Feb 2015 | Dbs Bank Ltd. | ₹5 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Cooper Pharma Limited
Cooper Pharma Limited has a workforce of 122 employees as of Mar 29, 2025.
Employee and EPFO history for Cooper Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cooper Pharma Limited
GST registrations and filing compliance for Cooper Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cooper Pharma Limited
Credit ratings, litigation, and regulatory alerts for Cooper Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cooper Pharma Limited
MSME payment history for Cooper Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cooper Pharma Limited
Corporate group structure for Cooper Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cooper Pharma Limited
MCA filings and documents for Cooper Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cooper Pharma Limited
Recent News on Cooper Pharma Limited
Frequently Asked Questions about Cooper Pharma Limited
Cooper Pharma Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 02 February 1989 (37+ years old) and is registered under CIN U24231DL1989PLC034902. The company has 122 employees.
Cooper Pharma Limited reported revenue of ₹63.28 Cr for FY 2024 (down 1.00% YoY).
The current directors of Cooper Pharma Limited are:
- Rakesh Bhargava - Managing Director
- Dinesh Kumar - Director
- Abhishek Bhargava - Whole-Time Director
The primary industry of Cooper Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Cooper Pharma Limited can be reached at the registered office: Plot No. – 5 Nidhi Plaza – Ii 2Nd Floor, L.S.C. Gulabi Bagh, Delhi, Delhi, India – 110052, or through the website cooperpharma.com.
The authorised capital is ₹3 Cr, and the paid-up capital is ₹1 Cr.